Magic mushroom compound enters final testing for depression
Disease control
Ongoing
This large, late-stage study is testing whether a single dose of psilocybin, the active compound in 'magic mushrooms,' can help treat major depression. About 240 adults with moderate to severe depression will receive either a high dose, a low dose, or a placebo pill, all with pro…
Phase: PHASE3 • Sponsor: Usona Institute • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC